Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE' / Šufliarsky J. ... [et al.]. -- Annals of oncology, May 5 (2018)

In Onkológia. -- Bratislava : SOLEN, 2018. -- s. 157-226. -- ISSN 1336-8176. -- Roč. 13, č. 3 (2018), s. 222

1. sarkóm svetlobunkový - farmakoterapia

I. Šufliarsky, Jozef
II. Redakcia Onkológia
III. Onkológia. -- Roč. 13, č. 3 (2018), s. 222

krizotinib